Literature DB >> 3830770

[Therapeutic effectiveness of PTT-119 evaluated in vivo in experimental models].

R Bianchi, B Nardelli, M Allegrucci, M C Fioretti.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3830770

Source DB:  PubMed          Journal:  G Ital Chemioter        ISSN： 0017-0445


× No keyword cloud information.
  2 in total

1.  Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.

Authors:  F Gherlinzoni; P Mazza; P L Zinzani; S Tura; F Lanza; G Castoldi; G Bellesi; P L Rossi Ferrini; L Mangoni; V Rizzoli
Journal:  Blut       Date:  1990-03

2.  Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.

Authors:  S Tura; P Mazza; F Gherlinzoni; P L Zinzani; G Poletti; G Visani; R M Lemoli; M Cavo; P Galieni; C Tassi
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.